Researchers are exploring various aspects of venous thromboembolism risk management in different patient populations, including those with cancer, covid-19, and other conditions. The risk of venous thromboembolism appears to be a concern in several groups, such as patients with amyotrophic lateral sclerosis and transgender women on hormone therapy. Studies and reviews are investigating the incidence, pathogenesis, and management of venous thromboembolism in these populations, with some focusing on the role of specific treatments and therapies.